Growth Hormone pp 261-279 | Cite as

Psychological Well-Being in Growth Hormone Deficiency and Central Nervous Effects of Growth Hormone

  • Jan-Ove Johansson
  • Bengt-Åke Bengtsson
Part of the Endocrine Updates book series (ENDO, volume 4)


Although no widely accepted definition of the term “quality of life” exists, the close relationship between quality of life and health is accepted. In recent years, there has been a growing interest in the assessment of quality of life in both medical care and clinical trials. Measures which have often been used in evaluating quality of life are for example the two self-rating questionnaires the Nottingham Health Profile (NHP) and the Psychological General Well-Being Index (PGWB).


Growth Hormone Growth Hormone Deficiency Growth Hormone Receptor Growth Hormone Treatment Growth Hormone Therapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Rotnem D, Genel M, Hintz RL, Cohen DJ. Personality development in children with growth hormone deficiency. J Am Acad Child Psychiatry 1977;16:412–426.PubMedCrossRefGoogle Scholar
  2. 2.
    Dean HJ, McTaggart TL, Fish DG, Friesen HG. The educational, vocational and marital status of growth hormone-deficient adults treated with growth hormone during childhood. Am J Dis Child 1985;139:1105–1110.PubMedGoogle Scholar
  3. 3.
    Galatzer A, Aran O, Beit-Halachmi N, Nofar E, Rubitchek J, Pertzelan A et al. The impact of long-term therapy by a multidisciplinary team on the education, occupation and marital status of growt hormone deficient patients after termination of therapy. Clin Endocrinol 1987;27:191–196.CrossRefGoogle Scholar
  4. 4.
    Björk S, Jönsson B, Westphal O, Levin J-E. Quality of life of adults with growth hormone deficiency: a controlled study. Acta Paediatr Scand (Suppl) 1989;356:55–59.CrossRefGoogle Scholar
  5. 5.
    McGauley GA. Quality of life assessment before and after growth hormone treatment in adults with growth hormone deficiency. Acta Paediatr Scand (Suppl) 1989;356:70–72.CrossRefGoogle Scholar
  6. 6.
    Rosén T, Wirén L, Wilhelmsen L, Wiklund I, Bengtsson B-Å. Decreased psychological well-being in adult patients with growth hormone deficiency. Clin Endocrinol (Oxf) 1994;40:111–116.CrossRefGoogle Scholar
  7. 7.
    Takano K, Tanaka T, Saito T and the members of the committee for the study group of adult GH-deficiency. Psychosocial consequences of growth hormone deficiency (GHD) in adults. Clin Pediatr Endocrinol 1994; 3 (Suppl 5):79–85.CrossRefGoogle Scholar
  8. 8.
    Rikken B, van Busschbach J, 1e Cessie S, Manten W, Spermon T, Grobbee R, Wit J-M. Impaired social status of growth hormone deficient adults as compared to controls with short or normal stature. Clin Endocrinol (Oxf) 1995;43:205–211.CrossRefGoogle Scholar
  9. 9.
    Burman P, Broman JE, Herta J, Wiklund I, Erfurth EM, Hägg E, Karlsson FA. Quality of life in adults with growth hormone (GH) deficiency: response to treatment with recombinant human GH in a placebo-controlled 21-month trial. J Clin Endocrinol Metab 1995;80:3585–3590.PubMedCrossRefGoogle Scholar
  10. 10.
    Deijen JB, de Boer H, Blok GJ, van der Veen EA. Cognitive impairments and mood disturbances in growth hormone deficient men. Psychoneuroendocrinology 1996;21:312–322.CrossRefGoogle Scholar
  11. 11.
    Raben MS. Clinical use of growth hormone. N Engl J Med 1962;266:82–86.PubMedCrossRefGoogle Scholar
  12. 12.
    Almqvist O, Thorén M, Sääf M, Eriksson O. Effects of growth hormone substitution on mental performance in adults with growth hormone deficiency: a pilot study. Psychoneuroendocrinology 1986;11:347–352.PubMedCrossRefGoogle Scholar
  13. 13.
    Bengtsson B-Å, Edén S, Lönn L, Kvist H, Stokland A, Lindstedt G, Bosaeus I, Tölli J, Sjöström L, Isaksson OGP. Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J Clin Endocrinol Metab 1993;76:309–317.PubMedCrossRefGoogle Scholar
  14. 14.
    Whitehead HM, Boreham C, Mcllrath EM, Sheridan B, Kennedy L, Atkinson AB, Hadden DR. Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo controlled cross-over study. Clin Endocrinol 1992;36:45–52.CrossRefGoogle Scholar
  15. 15.
    Mårdh G, Lundin K, Borg G, Jonsson B, Lindeberg A. Growth hormone replacement therapy in adult hypopituitary patients with growth hormone deficiency: combined data from 12 European placebo-controlled clinical trials. Endocrinol Metab 1994; 1(Suppl A):43–49.Google Scholar
  16. 16.
    Zamenhof S. Stimulation of the proliferation of neurons by the growth hormone: I. Experiments on tadpoles. Growth 1941;5:123–139.Google Scholar
  17. 17.
    Zamenhof S. Stimulation of cortical-cell proliferation by the growth hormone. III. Experiments on albino rats. Physiol Zool 1942;15:281–292.Google Scholar
  18. 18.
    Krieger DT. Pituitary hormones in the brain: what is their function ? Federation Proc 1980;39:2937–2941.Google Scholar
  19. 19.
    Hojvat S, Emanuele N, Baker G, Connick E, Kirsteins L, Lawrence AM. Growth hormone (GH), thyroid-stimulating hormone (TSH), and luteinizing hormone (LH)-like peptides in the rodent brain: non-parallel ontogenetic development with pituitary counterparts. Dev Brain Res 1982;4:427–434.CrossRefGoogle Scholar
  20. 20.
    Pacold ST, Kirsteins L, Hojvat S, Lawrence AM. Biologically active pituitary hormones in the rat brain amygdaloid nucleus. Science 1978;199:804–806.PubMedCrossRefGoogle Scholar
  21. 21.
    Van Houten M, Posner BI, Walsh RJ. Radioautographic identification of lactogen binding sites in rat median eminence using 125I-human growth hormone: evidence for a prolactin “short-loop feedback site. Exp Brain Res 1980;38:455–461.PubMedCrossRefGoogle Scholar
  22. 22.
    Kyle CV, Evans MC, Odell WD. Growth hormone-like material in normal human tissues. J Clin Endocrinol Metab 1981;53:1138–1144.PubMedCrossRefGoogle Scholar
  23. 23.
    Lechan RM, Nestler JL, Molitch ME. Immunohistochemical identification of a novel substance with human growth hormone-like immunoreactivity in rat brain. Endocrinology 1981;109:1950–1962.PubMedCrossRefGoogle Scholar
  24. 24.
    Hojvat S, Baker G, Kirsteins L, Lawrence AM. Growth hormone (GH) immunoreactivity in the rodent and primate CNS: distribution, characterization and presence posthypophysectomy. Brain Res 1982;239:543–557.PubMedCrossRefGoogle Scholar
  25. 25.
    Lechan RM, Molitch ME, Jackson IMD. Distribution of immunoreactive human growth hormone-like material and thyrotropin-releasing hormone in the rat central nervous system: evidence for their coexistence in the same neurons. Endocrinology 1983;112:877–884.PubMedCrossRefGoogle Scholar
  26. 26.
    Harvey S, Hull KL, Fraser RA. Growth hormone: neurocrine and neuroendocrine perspectives. Growth Regul 1993;3:161–171.PubMedGoogle Scholar
  27. 27.
    Gossard F, Dihl F, Pelletier G, Dubois PM, Morel G. In situ hybridization to rat brain and pituitary gland of growth hormone cDNA. Neurosci Lett 1987;79:251–256.PubMedCrossRefGoogle Scholar
  28. 28.
    Pelton EW, Grindeland RE, Young E, Bass NH. Effects of immunologically induced growth hormone deficiency on myelinogenesis in developing rat cerebrum. Neurology 1977;27:282–288.PubMedCrossRefGoogle Scholar
  29. 29.
    Noguchi T, Sugisaki T, Takamatsu K, Tsukada Y. Factors contributing to the poor myelination in the brain of the snell dwarf mouse. J Neurochem 1982;39:1693–1699.PubMedCrossRefGoogle Scholar
  30. 30.
    Noguchi T, Sugisaki T. Stimulatory effects of growth hormone and thyroxine on the concentration of gangliosides in the snell dwarf cerebrum. J Neurochem 1986;47:1785–1792.PubMedCrossRefGoogle Scholar
  31. 31.
    Noguchi T, Sugisaki T, Watanabe M, Kohsaka S, Tsukada Y. Effects of bovine growth hormone on the retarded cerebral development induced by neonatal hydrocortisone intoxication. J Neurochem 1982;38:246–256.PubMedCrossRefGoogle Scholar
  32. 32.
    Zamenhof S, Mosley J, Schuller E. Stimulation of the proliferation of cortical neurons by prenatal treatment with growth hormone. Science 1966;152:1396–1397.PubMedCrossRefGoogle Scholar
  33. 33.
    Block JB, Essman WB. Growth hormone administration during pregnancy: a behavioural difference in offspring rats. Nature 1965;205:1136–1137.PubMedCrossRefGoogle Scholar
  34. 34.
    Sara VR, Lazarus L, Stuart MC, King T. Fetal brain growth: selective action by growth hormone. Science 1974;186:446–447.PubMedCrossRefGoogle Scholar
  35. 35.
    Sara VR, Lazarus L. Prenatal action of growth hormone on brain and behaviour. Nature 1974;250:257–258.PubMedCrossRefGoogle Scholar
  36. 36.
    Rogers LJ, Schanberg SM, Fellows RE. Growth and lactogenic hormone stimulation of Ornithine decarboxylase in neonatal rat brain. Endocrinology 1974;95:904–911.CrossRefGoogle Scholar
  37. 37.
    Chen L, Lund PK, Burgess SB, Rudisch BE, Mcllwain DL. Growth hormone, insulin-like growth factor I, and motoneuron size. J Neurobiol 1997;32:202–212.PubMedCrossRefGoogle Scholar
  38. 38.
    Berti-Mattera LN, Gómez CJ, Krawiec L. Effects of bovine growth hormone on RNA synthesis in brain and liver of neonatal hypothyroid rats. Horm Metab Res 1983;15:286–289.PubMedCrossRefGoogle Scholar
  39. 39.
    Minami S, Kamegai J, Sugihara H, Hasegawa O, Wakabayashi I. Systemic administration of recombinant human growth hormone induces expression of the c-fos gene in the hypothalamic arcuate and periventricular nuclei in hypophysectomized rats. Endocrinology 1992;131:247–253.PubMedCrossRefGoogle Scholar
  40. 40.
    Kamegai J, Minami S, Sugihara H, Higuchi H, Wakabayashi I. Growth hormone induces expression of the c-fos gene on hypothalamic neuropeptide-Y and somatostatin neurons in hypophysectomized rats. Endocrinology 1994;135:2765–2771.PubMedCrossRefGoogle Scholar
  41. 41.
    Schneider-Rivas S, Rivas-Arancibia S, Vázquez-Pereyra F, Vázquez-Sandoval R, Borgonio-Pérez G. Modulation of long-term memory and extinction responses induced by growth hormone (GH) and growth hormone releasing hormone (GHRH) in rats. Life Sci 1995;56:433–441.CrossRefGoogle Scholar
  42. 42.
    Zhang J, Obál Jr. F, Fang J, Collins BJ, Krueger JM. Non-rapid eye movement sleep is supressed in transgenic mice with a deficiency in the somatotropic system. Neurosci Lett 1996;220:97–100.PubMedCrossRefGoogle Scholar
  43. 43.
    Pollitt E, Money J. Studies in the psychology of dwarfism. I. Intelligence quotient and school achievement. J Pediatr 1964;64:415–421.PubMedCrossRefGoogle Scholar
  44. 44.
    Laron Z, Galatzer A. Growth hormone, somatomedin and prolactinrelationship to brain function. Brain Dev 1985;7:559–567.PubMedCrossRefGoogle Scholar
  45. 45.
    Rosenbloom AL, Guevara-Aguirre J, Rosenfeld RG, Fielder PJ. The little women of Loja — Growth hormone-receptor deficiency in an inbred population of southern Ecuador. NEngl JMed 1990;323:1367–1374.CrossRefGoogle Scholar
  46. 46.
    Guvara-Aguirre J, Rosenbloom AL, Vaccarello MA, Fielder PJ, de la Vega A, Diamond Jr FB, Rosenfeld RG. Growth hormone receptor deficiency Laron Syndrome): clinical and genetic characteristics. Acta Paediatr Scand (Suppl) 1991;377:96–103.Google Scholar
  47. 47.
    Rosenfeld RG, Rosenbloom AL, Guevara-Aguirre J. Growth hormone (GH) insensitivity due to primary GH receptor deficiency. Endocr Rev 1994;15:369–390.PubMedGoogle Scholar
  48. 48.
    Di Carlo R, Muccioli G, Bellussi G, Pagnini G, Papotti M, Bussolati G. Lactogenic binding sites in the brain: regional distribution, species variation and characterization. Adv Biosci 1984;48:303–308.Google Scholar
  49. 49.
    Lai Z, Emtner M, Roos P, Nyberg F. Characterization of putative growth hormone receptors in human choroid plexus. Brain Res 1991;546:222–226.PubMedCrossRefGoogle Scholar
  50. 50.
    Lai Z, Roos P, Zhai Q, Olsson Y, Fhölenhag K, Larsson C, Nyberg F. Agerelated reduction of human growth hormone-binding sites in the human brain. Brain Res 1993;621:260–266.PubMedCrossRefGoogle Scholar
  51. 51.
    Lobie PE, Garcia-Aragon J, Lincoln DT, Barnard R, Wilcox JN, Waters MJ. Localization and ontogeny of growth hormone receptor gene expression in the central nervous system. Dev Brain Res 1993;74:225–233.CrossRefGoogle Scholar
  52. 52.
    Mustafa A, Nyberg F, Bogdanovic N, Islam A, Roos P, Adem A. Somatogenic and lactogenic binding sites in rat brain and liver: quantitative autoradiographic localization. Neurosci Res 1994;20:257–263.PubMedCrossRefGoogle Scholar
  53. 53.
    Nyberg F, Burman P. Growth hormone and its receptors in the central nervous system-location and functional significance. Horm Res 1996;45:18–22.PubMedCrossRefGoogle Scholar
  54. 54.
    Mathews LS, Enberg B, Norstedt G. Regulation of rat growth hormone receptor gene expression. J Biol Chem 1989;264:9905–9910.PubMedGoogle Scholar
  55. 55.
    Burton KA, Kabigting EB, Clifton DK, Steiner RA. Growth hormone receptor messenger ribonucleic acid distribution in the adult male rat brain and its colocalization in hypothalamic somatostatin neurons. Endocrinology 1992;131:958–963.PubMedCrossRefGoogle Scholar
  56. 56.
    Ilkbahar YN, Wu K, Thordarson G, Talamantes F. Expression and distribution of messenger ribonucleic acids for growth hormone (GH) receptor and GH-binding protein in mice during pregnancy. Endocrinology 1995;136:386–392.PubMedCrossRefGoogle Scholar
  57. 57.
    Lobie PE, Garcia-Aragon J, Wang BS, Baumbach WR, Waters MJ. Cellular localization of the growth hormone binding protein in the rat. Endocrinology 1992;130:3057–3065.PubMedCrossRefGoogle Scholar
  58. 58.
    Lobie PE, Ronsin B, Silvennoinen O, Haldorsén L-A, Norstedt G, Morel G. Constitutive nuclear localization of janus kinases 1 and 2. Endocrinology 1996;137:4037–4045.PubMedCrossRefGoogle Scholar
  59. 59.
    Argetsinger LS, Carter-Su C. Mechanism of signaling by growth hormone receptor. Physiol Rev 1996;76:1089–1107.PubMedGoogle Scholar
  60. 60.
    Linfoot JA, Garcia JF, Wei W, Fink R, Sarin R, Born JL, Lawrence JH. Human growth hormone levels in cerebrospinal fluid. J Clin Endocrinol Metab 1970;31:230–232.PubMedCrossRefGoogle Scholar
  61. 61.
    Belchetz PE, Ridley RM, Baker HF. Studies on the accessibility of prolactin and growth hormone to brain: effect of opiate agonists on hormone levels in serial, simultaneous plasma and cerebrospinal fluid samples in the rhesus monkey. Brain Res 1982;239:310–314.PubMedCrossRefGoogle Scholar
  62. 62.
    Stern WC, Miller M, Resnick O, Morgane PJ. Distribution of 125I-labelled rat growth hormone in regional brain areas and peripheral tissue of the rat. Am J Anat 1975;144:503–508.PubMedCrossRefGoogle Scholar
  63. 63.
    Stern WC, Miller M, Jalowiec JE, Forbes WB, Morgane PJ. Effects of growth hormone on brain biogenic amine levels. Pharmacol Biochem Behav 1975;3:1115–1118.PubMedCrossRefGoogle Scholar
  64. 64.
    Andersson K, Fuxe K, Eneroth P, Isaksson O, Nyberg F, Roos P. Rat growth hormone and hypothalamic catecholamine nerve terminal systems. Evidence for rapid and discrete reductions in dopamine and noradrenaline levels and turnover in the median eminence of the hypophysectomized male rat. Eur J Pharmacol 1983;95:271–275.PubMedCrossRefGoogle Scholar
  65. 65.
    Johansson J-O, Larson G, Andersson M, Elmgren A, Hynsjö L, Lindahl A, Lundberg P-A, Isaksson OGP, Lindstedt S, Bengtsson B-Å. Treatment of growth hormone-deficient adults with recombinant human growth hormone increases the concentration of growth hormone in the cerebrospinal fluid and affects neurotransmitters. Neuroendocrinology 1995;61:57–66.PubMedCrossRefGoogle Scholar
  66. 66.
    Burman P, Herta J, Wide L, Månsson J-E, Ekman R, Karlsson FA. Growth hormone treatment affects brain neurotransmitters and thyroxine. Clin Endocrinol (Oxf) 1996;44:319–324.CrossRefGoogle Scholar
  67. 67.
    Tomas FM, Knowles SE, Owens PC, Read LC, Chandler CS, Gargosky SE, Ballard FJ. Effects of full-length and truncated insulin-like growth factor-I on nitrogen balance and muscle protein metabolism in nitrogen-restricted rats. J Endocrinol 1991;128:97–105.PubMedCrossRefGoogle Scholar
  68. 68.
    Yamamoto H, Murphy LJ. Generation of des-(l-3) insulin-like growth factor-I in serum by an acid protease. Endocrinology 1994;135:2432–2439.PubMedCrossRefGoogle Scholar
  69. 69.
    Sara VR, Hall K, von Holtz H, Humbel R, Sjögren B, Wetterberg L. Evidence for the presence of specific receptors for insulin-like growth factors 1 (IGF-1) and 2 (IGF-2) and insulin throughout the adult human brain. Neurosci Lett 1982;34:39–44.PubMedCrossRefGoogle Scholar
  70. 70.
    Carlsson-Skwirut C, Jörnvall H, Holmgren A, Andersson C, Bergman T, Lundquist G, Sjögren B, Sara VR. Isolation and characterization of variant IGF-1 as well as IGF-2 from adult human brain. FEBS Lett 1986;201:46–50.PubMedCrossRefGoogle Scholar
  71. 71.
    Adem A, Jossan SS, d’Argy R, Gillberg PG, Nordberg A, Winblad B, Sara V. Insulin-like growth factor 1 (IGF-1) receptors in the human brain: quantitative autoradiographic localization. Brain Res 1989;503:299–303.PubMedCrossRefGoogle Scholar
  72. 72.
    Bondy CA, Lee W-H. Patterns of insulin-like growth factor and IGF receptor gene expression in the brain. Functional implications. Ann NY Acad Sci 1993;692:33–43.PubMedCrossRefGoogle Scholar
  73. 73.
    de Keyser J, Wilczak N, de Backer J-P, Herroelen L, Vauquelin G. Insulinlike growth factor-I receptors in human brain and pituitary gland: an autoradiographic study. Synapse 1994;17:196–202.PubMedCrossRefGoogle Scholar
  74. 74.
    Lesniak MA, Hill JM, Kiess W, Rojeski M, Pert CB, Roth J. Receptors for insulin-like growth factors I and II: Autoradiographic localization in rat brain and comparison to receptors for insulin. Endocrinology 1988;123:2089–2099.PubMedCrossRefGoogle Scholar
  75. 75.
    Rotwein P, Burgess SK, Milbrandt JD, Krause JE. Differential expression of insulin-like growth factor genes in rat central nervous system.. Proc Natl Acad Sci USA, 1988;85:265–269.PubMedCrossRefGoogle Scholar
  76. 76.
    Bondy CA. Transient IGF-I gene expression during the maturation of functionally related central projection neurons. J Neurosci 1991;11:3442–3455.PubMedGoogle Scholar
  77. 77.
    Aguado F, Sánchez-Franco F, Rodrigo J, Cacicedo L, Martínez-Murillo R. Insulin-like growth factor I-immunoreactive peptide in adult human cerebellar purkinje cells: co-localization with low-affinity nerve growth factor receptor. Neuroscience 1994;59:641–650.PubMedCrossRefGoogle Scholar
  78. 78.
    Bach MA, Shen-Orr Z, Lowe Jr. WL, Roberts Jr. CT, LeRoith D. Insulinlike growth factor I mRNA levels are developmentally regulated in specific regions of the rat brain. Mol Brain Res 1991;10:43–48.PubMedCrossRefGoogle Scholar
  79. 79.
    Stylianopoulou F, Herbert J, Soares MB, Efstratiadis A. Expression of the insulin-like growth factor II gene in the choroid plexus and the leptomeninges of the adult rat central nervous system. Proc Natl Acad Sci USA 1988;85:141–145.PubMedCrossRefGoogle Scholar
  80. 80.
    Haselbacher G, Humbel R. Evidence for two species of insulin-like growth factor II (IGF II and “big” IGF II) in human spinal fluid Endocrinology 1982;110:1822–1824.PubMedCrossRefGoogle Scholar
  81. 81.
    Nilsson C, Mørck Hultberg B, Gammeltoft S. Automne role of insulin-like growth factor II secretion by the rat choroid plexus. Eur J Neurosci 1996;8:629–635.PubMedCrossRefGoogle Scholar
  82. 82.
    Bäckström M, Hall K, Sara V. Somatomedin levels in cerebrospinal fluid from adults with pituitary disorders. Acta Endocrinol (Copenh) 1984;107:171–178.Google Scholar
  83. 83.
    Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 1995;16:3–34.PubMedGoogle Scholar
  84. 84.
    Aizenman Y, de Vellis J. Brain neurons develop in a serum and glial free environment: effects of transferrin, insulin, insulin-like growth factor-I and thyroid hormone on neuronal survival, growth and differentiation. Brain Res 1987;406:32–42.PubMedCrossRefGoogle Scholar
  85. 85.
    DiCicco-Bloom E, Black IB. Insulin growth factors regulate the mitotic cycle in cultured rat sympathetic neuroblasts. Proc Natl Acad Sci USA 1988;85:4066–4070.PubMedCrossRefGoogle Scholar
  86. 86.
    Caroni P, Grandes P. Nerve sprouting in innervated adult skeletal muscle induced by exposure to elevated levels of insulin-like growth factors. J Cell Biol 1990;110:1307–1317.PubMedCrossRefGoogle Scholar
  87. 87.
    Bondy C, Werner H, Roberts Jr. CT, LeRoith D. Cellular pattern of type-I insulin-like growth factor receptor gene expression during maturation of the rat brain: comparison with insulin-like growth factors I and II. Neuroscience 1992;46:909–923.PubMedCrossRefGoogle Scholar
  88. 88.
    Sara VR, Carlsson-Skwirut C. The role of the insulin-like growth factors in the regulation of brain development. Prog Brai Res 1988;73:87–99.CrossRefGoogle Scholar
  89. 89.
    McMorris FA, Smith TM, DeSalvo S, Furlanetto RW. Insulin-like growth factor I/somatomedin C: a potent inducer of oligodendrocyte development. Proc Natl Acad Sci USA, 1986;83:822–826.PubMedCrossRefGoogle Scholar
  90. 90.
    Carson MJ, Behringer RR, Brinster RL, McMorris FA. Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice. Neuron 1993;10:729–740.PubMedCrossRefGoogle Scholar
  91. 91.
    Ye P, Carson J, D’Ercole AJ. In vivo actions of insulin-like growth factor-I (IGF-I) on brain myelination: studies of IGF-I and IGF binding protein-1 (IGFBP-1) transgenic mice. J Neurosci 1995;15:7344–7356.PubMedGoogle Scholar
  92. 92.
    Werner H, Raizada MK, Mudd LM, Foyt HL, Simpson IA, Roberts Jr. CT, LeRoith D. Regulation of rat brain/HepG2 glucose transporter gene expression by insulin and insulin-like growth factor-I in primary cultures of neuronal and glial cells. Endocrinology 1989;125:314–320.PubMedCrossRefGoogle Scholar
  93. 93.
    D’Ercole AJ, Dai Z, Xing Y, Boney C, Wilkie MB, Lauder JM, Han VKM, Clemmons DR. Brain growth retardation due to the expression of human insulin-like growth factor binding protein-1 in transgenic mice: an in vivo model for the analysis of igf function in the brain. Dev Brain Res 1994;82:213–222.CrossRefGoogle Scholar
  94. 94.
    Yamaguchi F, Itano T, Miyamoto O, Janjua NA, Ohmoto T, Hosokawa K, Hatase O. Increase of extracellular insulin-like growth factor I (IGF-I) concentration following electrolytical lesion in rat hippocampus. Neurosci Lett 1991;128:273–276.PubMedCrossRefGoogle Scholar
  95. 95.
    Garcia-Estrada J, Garcia-Segura LM, Torres-Aleman I. Expression of insulin-like growth factor I by astrocytes in response to injury. Brain Res 1992;592:343–347.PubMedCrossRefGoogle Scholar
  96. 96.
    Gluckman P, Klempt N, Guan J, Mallard C, Sirimanne E, Dragunow M, Klempt M, Singh K, Williams C, Nicolics K. A role for IGF-1 in the rescue of CNS neurons following hypoxic-ischemic injury. Biochem Biophys Res Comm 1992;182:593–599.PubMedCrossRefGoogle Scholar
  97. 97.
    Gluckman PD, Guan J, Beilharz EJ, Klempt ND, Klempt M, Miller O, Sirimanne E, Dragunow M, Williams CE. The role of the insulin-like growth factor system in neuronal rescue. Ann NY Acad Sci 1993;692:138–148.PubMedCrossRefGoogle Scholar
  98. 98.
    Johnston BM, Mallard EC, Williams CE, Gluckman PD. Insulin-like growth factor-1 is a potent neuronal rescue agent after hypoxic-ischemic injury in fetal lambs. J clin Invest 1996;97:300–308.PubMedCrossRefGoogle Scholar
  99. 99.
    Bergstedt K, Wieloch T. Changes in insulin-like growth factor 1 receptor density after transient cerebral ischemia in the rat. Lack of protection against ischemic brain damage following injection of insulin-like growth factor 1. J Cereb Blood How Metab 1993;13:895–898.CrossRefGoogle Scholar
  100. 100.
    Ocrant I. Insulin-like growth factor binding proteins in nervous-tissuederived cells. Ann NY Acad Sci 1993;692:44–50.PubMedCrossRefGoogle Scholar
  101. 101.
    Guan J, Williams CE, Skinner SJM, Mallard EC, Gluckman PD. The effects of insulin-like growth factor (IGF)-l, IGF-2, and des-IGF-1 on neuronal loss after hypoxic-ischemic brain injury in adult rats: evidence for a role for IGF binding proteins. Endocrinology 1996;137:893–898.PubMedCrossRefGoogle Scholar
  102. 102.
    Kirschner PB, Henshaw R, Weise J, Trubetskoy V, Finklestein S, Schulz JB, Beal MF. Basic fibroblast growth factor protects against excitotoxicity and chemical hypoxia in both neonatal and adult rats. J Cereb Blood Flow Metab 1995;15:619–623.PubMedCrossRefGoogle Scholar
  103. 103.
    Cheng B, Mattson MP. NGF and bFGF protect rat hippocampal and human cortical neurons against hypoglycemic damage by stabilizing calcium homeostasis. Neuron 1991;7:1031–1041.PubMedCrossRefGoogle Scholar
  104. 104.
    Reinhardt RR, Bondy CA. Insulin-like growth factors cross the blood-brain barrier. Endocrinology 1994;135:1753–1761.PubMedCrossRefGoogle Scholar
  105. 105.
    Hodgkinson SC, Spencer GSG, Bass JJ, Davis SR, Gluckman PD. Distribution of circulating insulin-like growth factor-I (IGF-I) into tissues. Endocrinology 1991;129:2085–2093.PubMedCrossRefGoogle Scholar
  106. 106.
    Pardridge WM. Transport of insulin-related peptides and glucose across the blood-brain barrier. Ann NY Acad Sci 1993;692:126–137.PubMedCrossRefGoogle Scholar
  107. 107.
    Van Wyk JJ. The somatomedins: biological actions and physiologic control mechanisms. In: Li CH (Ed). Hormonal proteins and peptides: growth factors. Academic press, New York. 1984;12:81–125.Google Scholar
  108. 108.
    Hynes MA, Van Wyk JJ, Brooks PJ, D’Ercole AJ, Jansen M, Lund PK. Growth hormone dependence of somatomedin-C/insulin-like growth factor-I and insulin-like growth factor-II messenger ribonucleic acids. Mol Endocrinology 1987;1:233–242.CrossRefGoogle Scholar
  109. 109.
    López-Fernández J, Sánchez-Franco F, Velasco B, Tolón RM, Pazos F, Cacicedo L Growth hormone induces somatostatin and insulin-like growth factor I gene expression in the cerebral hemispheres of aging rats. Endocrinology 1996;137:4384–4391.PubMedCrossRefGoogle Scholar
  110. 110.
    Ågren H, Mefford IN, Rudorfer MV, Linnoila M, Potter WZ. Interacting neurotransmitter systems. A non-experimental approach to the 5HIAA-HVA correlation in human CSF. J Psychiatr Res 1986;20:175–193.PubMedCrossRefGoogle Scholar
  111. 111.
    Risby ED, Hsiao JK, Sunderland T, Ågren H, Rudorfer MV, Potter WZ. The effects of antidepressants on the cerebrospinal fluid homovanillic acid/5-hydroxyindoleacetic acid ratio. Clin Pharmacol Ther 1987:42:547–554.PubMedCrossRefGoogle Scholar
  112. 112.
    Reddy PL, Khanna S, Subhash MN, Channabasavanna SM, Rao BSSR. CSF amine metabolites in depression. Biol Psychiatry 1992;31:112–118.PubMedCrossRefGoogle Scholar
  113. 113.
    Schlachter LB, Wardlaw SL, Tindall GT, Frantz AG. Persistence of ß-endorphin in human cerebrospinal fluid after hypophysectomy. J Clin Endocrinol Metab 1983;57:221–224.PubMedCrossRefGoogle Scholar
  114. 114.
    Johansson P, Ray A, Lai Z, Zhai Q-Z, Roos P, Nyberg F. Effects of intracerebroventricular injections of growth hormone on Opioid peptides in the male rat. Analgesia 1995;1;4–6:481-485.Google Scholar
  115. 115.
    Bruhn TO, Tresco PA, Mueller GP, Jackson IMD. Beta-endorphin mediates Clonidine stimulated growth hormone release. Neuroendocrinology 1989;50:460–463.PubMedCrossRefGoogle Scholar
  116. 116.
    Delitala G, Tomasi PA, Palermo M, Ross RJM, Grossman A, Besser GM. Opioids stimulate growth hormone (GH) release in man independently of GH-releasing hormone. J Clin Endocrinol Metab 1989;69:356–358.PubMedCrossRefGoogle Scholar
  117. 117.
    Zhai QZ, Lai Z, Yukhananov R, Roos P, Nyberg F. Decreased binding of growth hormone in the rat hypothalamus and choroid plexus following morphine treatment. Neurosci Lett 1995;184:82–85.PubMedCrossRefGoogle Scholar
  118. 118.
    Janal MN, Colt EWD, Clark WC, Glusman M. Pain sensitivity, mood and plasma endocrine levels in man following long-distance running: effects of Naloxone. Pain 1984;19:13–25.PubMedCrossRefGoogle Scholar
  119. 119.
    Morgan WP. Affective beneficence of vigorous physical activity. Med Sci Sports Exerc 1985;17:94–100.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1999

Authors and Affiliations

  • Jan-Ove Johansson
    • 1
  • Bengt-Åke Bengtsson
    • 1
  1. 1.Research Centre for Endocrinology and MetabolismSahlgrenska University HospitalGöteborgSweden

Personalised recommendations